Progesterone Market on Track for Strong Growth, Estimated to Grow at 14.6% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Progesterone Market Through 2025?
The size of the progesterone market has expanded swiftly over the past few years. Its expansion is predicted to continue from $1.56 billion in 2024 to $1.79 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.9%. The growth experienced in the past can be credited to factors such as the growing numbers of infertility cases, the expanded use in assisted reproductive technology, an increase in the prevalence of menstrual disorders, a heightened awareness of women's health, and an escalating demand for bioidentical hormones.

What's the Projected Size of the Global Progesterone Market by 2029?
In the coming years, the progesterone market size is projected to expand rapidly, reaching a valuation of $3.09 billion by 2029, with a compound annual growth rate (CAGR) of 14.6%. The growth during this projection period can be tied to several factors including the increasing size of the elderly female population, the escalating occurrence of hormonal imbalances, the rising preference for transdermal and injectable delivery methods, an increasing emphasis on preventive healthcare, and growing healthcare expenditure. The forecast period is expected to witness several trends such as advancements in transdermal delivery systems, the development of sustained-release formulations, innovations in bioidentical hormone compounding, improvements in oral bioavailability technologies and the introduction of smart drug delivery patches.

View the full report here:
https://www.thebusinessresearchcompany.com/report/progesterone-global-market-report

Top Growth Drivers in the Progesterone Industry: What's Accelerating the Market?
Growth in the progesterone market is anticipated due to the escalating occurrence of hormonal disorders. These disorders are medical conditions stemming from the endocrine system's imbalances, responsible for creating hormones that regulate crucial functions like metabolism, mood, growth, and reproduction. A rise in hormonal disorders can be attributed to contemporary lifestyle elements such as inadequate diet, persistent stress, insufficient exercise, and contact with environmental hazards. Progesterone plays a critical role in managing these disorders, as it reinstates hormonal stability, governs menstrual cycles, and lessens symptoms associated with estrogen dominance. Additionally, it aids the function of other hormones like estrogen and cortisol, thereby stabilising the overall activity of the endocrine system and easing conditions like polycystic ovary* syndrome (PCOS) and premenstrual syndrome (PMS). For example, the World Health Organization, based in Switzerland, revealed in January 2025 that PCOS poses a significant public health concern as it represents one of the most prevalent hormonal disorders in females of reproductive age, impacting 6-13% annually. Consequently, the growing occurrence of hormonal disorders stimulates the progesterone market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24671&type=smp

What Trends Will Shape the Progesterone Market Through 2029 and Beyond?
Leading corporations in the progesterone market are concentrating on creating novel formulations, like soft vaginal capsules, to increase adherence to treatment and ameliorate drug absorption. These capsules are soft, jelly-like inserts specifically intended for vaginal use that facilitate the delivery of medication directly to the vaginal region for managing infections, ensuring hormonal equilibrium, or preserving overall vaginal wellbeing. For example, Besins Healthcare (UK) Limited, a pharmaceutical manufacturer based in the UK, rolled out Prometrium 400mg soft vaginal capsules in April 2024. These capsules assist in preventing miscarriages in women who have had early pregnancy bleeding and a prior history of repeated miscarriages. This unique formulation, the first licensed product of its kind in the UK, is designed to boost patient compliance and therapeutic results by providing a focused, non-invasive delivery mechanism that augments progesterone absorption at the requisite site.

What Are the Main Segments in the Progesterone Market?
The progesterone market covered in this report is segmented -

1) By Product Type: Natural Progesterone, Synthetic Progesterone
2) By Drug Type: Branded, Generic
3) By Route Of Administration: Injectable, Oral, Transdermal, Other Routes Of Administration
4) By Application: Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications
5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:
1) By Natural Progesterone: Oral Capsules, Vaginal Gels, Creams, Injections, Suppositories
2) By Synthetic Progesterone: Progestins, Oral Contraceptives, Hormone Replacement Therapy (HRT) Formulations, Injectable Contraceptives, Intrauterine Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24671&type=smp

Which Top Companies are Driving Growth in the Progesterone Market?
Major companies operating in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy's Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.

Which Regions Will Dominate the Progesterone Market Through 2029?
North America was the largest region in the progesterone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the progesterone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24671

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.